Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Teladoc to Participate in Upcoming Investor Conference

Posted on: 25 Jul 18

PURCHASE, NY, July 25, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE:TDOC), the global leader in virtual care, announced today that Mark Hirschhorn, chief operating officer and chief financial officer, will participate in the following upcoming investor event:

  • The 38th Annual Canaccord Genuity Growth Conference, to be held in Boston, Mass., on Wednesday, August 8, 2018, including a fireside chat at 2:30 p.m. eastern.

About Teladoc, Inc.
Teladoc, Inc. (NYSE:TDOC) is the global leader in virtual care. A mission-driven organization, Teladoc is successfully expanding access to high quality healthcare, lowering costs and improving outcomes around the world. The company’s award winning, integrated clinical solutions are inclusive of telehealth, expert medical opinions, AI and analytics, and licensable platform services. With more than 2000 employees, the organization delivers care in 125 countries and in more than 20 languages, partnering with employers, hospital and health systems and insurers to transform care delivery. For more information, please visit or follow @Teladoc on Twitter.

Investor Contacts:
Bob East
Asher Dewhurst
Westwicke Partners

Media Contact:
Courtney McLeod
Director of Communications, Teladoc


Last updated on: 25/07/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.